Page last updated: 2024-09-03

1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol and etanidazole

1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol has been researched along with etanidazole in 1 studies

*Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy. [MeSH]

*Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy. [MeSH]

Compound Research Comparison

Studies
(1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol)
Trials
(1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol)
Recent Studies (post-2010)
(1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol)
Studies
(etanidazole)
Trials
(etanidazole)
Recent Studies (post-2010) (etanidazole)
19003264943

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeGraff, WG; Gamson, J; Mitchell, JB; Russo, A1

Other Studies

1 other study(ies) available for 1-(2-nitro-1-imidazoly)-3-(2,3-dimethylaziridino)-2-propanol and etanidazole

ArticleYear
Evaluation of nitroimidazole hypoxic cell radiosensitizers in a human tumor cell line high in intracellular glutathione.
    International journal of radiation oncology, biology, physics, 1989, Volume: 16, Issue:4

    Topics: Cell Line; Drug Evaluation, Preclinical; Etanidazole; Glutathione; Humans; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Tumor Cells, Cultured

1989